NPI: 1821035940 · AKRON, OH 44307 · General Acute Care Hospital · NPI assigned 05/31/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 05/31/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 116,158 | $4.46M |
| 2019 | 120,864 | $5.14M |
| 2020 | 105,346 | $5.79M |
| 2021 | 153,455 | $7.18M |
| 2022 | 197,225 | $9.14M |
| 2023 | 817,119 | $41.09M |
| 2024 | 579,833 | $26.20M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 180,297 | 149,738 | $16.63M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 65,690 | 55,088 | $9.31M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 65,598 | 59,755 | $7.71M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 59,870 | 51,885 | $7.70M |
| 96361 | Intravenous infusion, hydration; each additional hour | 21,651 | 13,842 | $7.21M |
| J9271 | Injection, pembrolizumab, 1 mg | 449 | 247 | $3.38M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 36,465 | 14,824 | $2.86M |
| 70450 | Computed tomography, head or brain; without contrast material | 8,547 | 6,641 | $2.28M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8,990 | 6,772 | $2.19M |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 987 | 253 | $1.63M |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 5,533 | 2,549 | $1.31M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9,583 | 5,635 | $1.30M |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 12,182 | 1,987 | $1.26M |
| G0378 | Hospital observation service, per hour | 14,891 | 6,232 | $1.21M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 8,252 | 6,485 | $925K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 7,037 | 3,812 | $923K |
| 80053 | Comprehensive metabolic panel | 82,220 | 65,078 | $831K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,873 | 2,180 | $819K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,271 | 2,995 | $806K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3,738 | 2,847 | $765K |
| 20610 | 4,360 | 2,453 | $709K | |
| 95886 | 2,534 | 2,377 | $691K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15,457 | 13,206 | $599K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,558 | 1,241 | $591K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 10,253 | 5,970 | $564K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 655 | 472 | $562K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,203 | 1,805 | $562K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,290 | 3,740 | $509K |
| 20553 | 3,266 | 2,937 | $456K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,349 | 2,406 | $436K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 825 | 610 | $385K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 15,462 | 13,218 | $343K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,269 | 1,075 | $333K |
| 62323 | 788 | 641 | $328K | |
| 90837 | Psychotherapy, 53 minutes with patient | 2,233 | 1,628 | $323K |
| 59025 | Fetal non-stress test | 1,933 | 1,092 | $318K |
| 64493 | 438 | 313 | $312K | |
| 84443 | Thyroid stimulating hormone (TSH) | 21,777 | 18,434 | $304K |
| 70498 | 1,001 | 757 | $303K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2,462 | 2,014 | $300K |
| 97810 | 8,680 | 5,142 | $294K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,000 | 2,471 | $279K |
| 52000 | 474 | 387 | $276K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 114,566 | 90,990 | $273K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 6,761 | 2,806 | $273K |
| 97113 | 3,468 | 1,164 | $261K | |
| 36415 | Collection of venous blood by venipuncture | 169,906 | 125,358 | $253K |
| 71046 | Radiologic examination, chest; 2 views | 19,916 | 16,422 | $252K |
| 96415 | 930 | 510 | $249K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 388 | 345 | $245K |
| 80048 | Basic metabolic panel (calcium, ionized) | 35,029 | 24,865 | $240K |
| 70491 | 745 | 561 | $237K | |
| 97161 | 5,190 | 4,570 | $231K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 7,758 | 3,758 | $229K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,858 | 1,309 | $223K |
| 96127 | 3,941 | 3,037 | $222K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 10,782 | 9,228 | $210K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 12,130 | 7,210 | $197K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9,670 | 6,496 | $187K |
| 76642 | 1,478 | 1,244 | $187K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,415 | 3,851 | $181K |
| 97535 | Self-care/home management training, each 15 minutes | 5,083 | 3,631 | $178K |
| 90791 | Psychiatric diagnostic evaluation | 886 | 746 | $177K |
| 80061 | Lipid panel | 14,247 | 12,127 | $176K |
| 76770 | 1,087 | 961 | $172K | |
| 90870 | 401 | 110 | $163K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 723 | 633 | $162K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 951 | 853 | $158K |
| 97597 | 2,711 | 1,689 | $158K | |
| 86850 | 6,071 | 4,750 | $153K | |
| C1776 | Joint device (implantable) | 96 | 69 | $152K |
| 71250 | 1,556 | 1,405 | $148K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 16,136 | 13,155 | $147K |
| 85027 | 24,742 | 18,103 | $146K | |
| 97811 | 8,569 | 5,073 | $146K | |
| 93975 | 1,520 | 1,128 | $143K | |
| 76536 | 1,336 | 1,178 | $142K | |
| 86780 | 5,543 | 4,731 | $139K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3,471 | 2,915 | $137K |
| 64483 | 280 | 236 | $135K | |
| 88142 | 6,422 | 5,750 | $134K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,253 | 1,969 | $132K |
| 93971 | 1,757 | 1,443 | $132K | |
| 84702 | 5,788 | 4,240 | $130K | |
| J0897 | Injection, denosumab, 1 mg | 156 | 116 | $127K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,030 | 906 | $126K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 820 | 678 | $126K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 91 | 63 | $125K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,619 | 3,147 | $123K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 539 | 453 | $121K |
| 83036 | Hemoglobin; glycosylated (A1C) | 16,275 | 13,992 | $121K |
| 49083 | 261 | 112 | $120K | |
| 90677 | 753 | 603 | $117K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 1,355 | 594 | $115K |
| 72141 | 661 | 580 | $114K | |
| 93970 | 796 | 665 | $114K | |
| 76801 | 823 | 736 | $114K | |
| 96367 | 1,961 | 1,113 | $113K | |
| 84439 | 7,672 | 6,697 | $113K | |
| 64635 | 175 | 128 | $109K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,059 | 915 | $105K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1,012 | 875 | $105K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6,280 | 5,268 | $105K |
| 95811 | 175 | 148 | $104K | |
| 93017 | 1,171 | 897 | $102K | |
| 74183 | 448 | 387 | $102K | |
| 12001 | 627 | 529 | $99K | |
| 76830 | Ultrasound, transvaginal | 1,409 | 1,042 | $99K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6,039 | 4,976 | $99K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 322 | 253 | $98K |
| 82607 | 5,061 | 4,112 | $94K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 679 | 609 | $93K |
| 97802 | 1,364 | 1,082 | $93K | |
| 20550 | 589 | 345 | $92K | |
| 86140 | 7,704 | 6,621 | $91K | |
| 93321 | 520 | 420 | $90K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 352 | 318 | $89K |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,491 | 2,793 | $87K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 770 | 677 | $87K |
| 73221 | 418 | 377 | $86K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,252 | 1,996 | $86K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 304 | 195 | $84K |
| 86803 | 4,513 | 3,657 | $84K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 644 | 372 | $83K |
| 86900 | 6,128 | 4,779 | $82K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,624 | 1,461 | $81K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 905 | 604 | $78K |
| 82728 | 5,758 | 4,664 | $78K | |
| 72100 | 2,943 | 2,398 | $78K | |
| 10060 | 487 | 391 | $78K | |
| 97165 | 1,361 | 1,124 | $77K | |
| 87808 | 5,933 | 4,695 | $77K | |
| 72131 | 910 | 741 | $75K | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 592 | 192 | $74K |
| 81513 | 626 | 555 | $73K | |
| 93325 | 801 | 670 | $73K | |
| 73630 | 4,331 | 3,578 | $70K | |
| 97162 | 2,030 | 1,711 | $69K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,192 | 443 | $69K |
| 87905 | 6,131 | 4,893 | $65K | |
| 73030 | 3,439 | 2,751 | $65K | |
| 87340 | 3,052 | 2,526 | $62K | |
| 93798 | 1,061 | 155 | $62K | |
| 73130 | 3,297 | 2,647 | $61K | |
| 88307 | 575 | 365 | $60K | |
| 94060 | 460 | 420 | $57K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 85 | 80 | $57K |
| 86762 | 1,861 | 1,642 | $56K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,196 | 884 | $56K |
| 70486 | 1,033 | 813 | $54K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 31,488 | 25,463 | $53K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 298 | 258 | $53K |
| 93308 | 188 | 151 | $52K | |
| 83970 | 1,905 | 1,507 | $50K | |
| 77336 | 499 | 216 | $49K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,862 | 579 | $49K |
| 84484 | 21,153 | 11,094 | $48K | |
| 36430 | 418 | 267 | $48K | |
| 80074 | 2,005 | 1,825 | $47K | |
| 87631 | 266 | 217 | $47K | |
| 19083 | 48 | 40 | $46K | |
| 78264 | 222 | 181 | $46K | |
| 83540 | 5,132 | 4,159 | $45K | |
| 73610 | 3,077 | 2,491 | $45K | |
| Q3014 | Telehealth originating site facility fee | 1,892 | 1,820 | $44K |
| 72050 | 1,286 | 1,107 | $44K | |
| 73564 | 2,035 | 1,620 | $44K | |
| 81001 | 55,183 | 46,366 | $43K | |
| 72110 | 1,178 | 1,049 | $42K | |
| 86901 | 6,129 | 4,779 | $41K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,152 | 816 | $40K |
| 27096 | 99 | 80 | $40K | |
| 62321 | 79 | 66 | $39K | |
| 83992 | 1,661 | 991 | $39K | |
| 0002A | 1,034 | 1,022 | $39K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 14,803 | 8,769 | $39K |
| 74018 | 1,394 | 1,038 | $39K | |
| 82570 | 4,692 | 3,842 | $38K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 3,755 | 2,438 | $38K |
| 0001A | 1,082 | 1,062 | $38K | |
| 12002 | 247 | 191 | $37K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 1,978 | 702 | $37K |
| 97166 | 845 | 707 | $37K | |
| 80076 | 4,038 | 3,032 | $37K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,577 | 1,544 | $37K |
| 77080 | 568 | 502 | $36K | |
| 87210 | 1,698 | 1,383 | $36K | |
| 74174 | 390 | 294 | $36K | |
| 76813 | 434 | 376 | $35K | |
| 98940 | 599 | 467 | $35K | |
| 83550 | 5,076 | 4,109 | $35K | |
| 73110 | 2,205 | 1,741 | $35K | |
| 72040 | 922 | 748 | $34K | |
| 94726 | 521 | 465 | $34K | |
| 93296 | 1,915 | 1,846 | $33K | |
| 73502 | 1,807 | 1,416 | $33K | |
| 90715 | 2,262 | 1,792 | $32K | |
| 83735 | 13,417 | 8,951 | $32K | |
| 87653 | 997 | 822 | $32K | |
| 70496 | 1,079 | 809 | $30K | |
| 94729 | 604 | 546 | $30K | |
| 86038 | 1,491 | 1,177 | $29K | |
| 87077 | 4,449 | 3,478 | $29K | |
| 86480 | 859 | 714 | $29K | |
| 73560 | 1,884 | 1,503 | $29K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 25,897 | 19,309 | $28K |
| 20600 | 145 | 78 | $28K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 846 | 808 | $28K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 49 | 41 | $28K |
| 86592 | 1,032 | 965 | $27K | |
| 97803 | 362 | 330 | $26K | |
| 77062 | 745 | 624 | $26K | |
| 80345 | 1,661 | 991 | $26K | |
| 90834 | Psychotherapy, 45 minutes with patient | 161 | 121 | $26K |
| 82962 | 13,578 | 4,778 | $26K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4,522 | 3,382 | $26K |
| 97116 | 1,251 | 677 | $25K | |
| 76857 | 1,374 | 1,014 | $25K | |
| 90688 | 1,446 | 1,020 | $25K | |
| 76882 | 266 | 212 | $25K | |
| 82784 | 1,899 | 1,527 | $25K | |
| 85610 | 6,395 | 4,347 | $24K | |
| 87522 | Neg quan hep c or qual rna | 789 | 630 | $24K |
| 82805 | 838 | 605 | $24K | |
| 77061 | 608 | 517 | $24K | |
| 85652 | 7,168 | 6,177 | $23K | |
| 99152 | 663 | 495 | $23K | |
| 80197 | 1,576 | 845 | $23K | |
| 64450 | 117 | 91 | $23K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2,602 | 2,143 | $21K |
| 55250 | 14 | 13 | $20K | |
| 73700 | 179 | 147 | $20K | |
| 93246 | 259 | 225 | $20K | |
| 74178 | 79 | 68 | $20K | |
| 71045 | Radiologic examination, chest; single view | 6,300 | 4,733 | $20K |
| 84153 | 1,421 | 1,213 | $19K | |
| 82746 | 2,413 | 1,938 | $19K | |
| 86706 | 1,183 | 958 | $19K | |
| 95813 | 17 | 12 | $19K | |
| 77300 | 45 | 29 | $18K | |
| 73140 | 1,007 | 822 | $18K | |
| 87497 | 689 | 343 | $18K | |
| 74019 | 460 | 392 | $17K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,320 | 965 | $17K |
| 77065 | Tomosynthesis, mammo | 900 | 736 | $17K |
| 96523 | 416 | 289 | $17K | |
| 80069 | 1,167 | 883 | $17K | |
| 82043 | 2,932 | 2,506 | $17K | |
| 96368 | 709 | 436 | $16K | |
| 95913 | 129 | 116 | $16K | |
| 97164 | 256 | 230 | $16K | |
| 86364 | 842 | 682 | $16K | |
| 84481 | 1,727 | 1,508 | $16K | |
| 72170 | 1,455 | 1,134 | $15K | |
| 84403 | 1,007 | 866 | $15K | |
| 80346 | 1,705 | 1,029 | $15K | |
| 80348 | 1,675 | 1,003 | $15K | |
| 95819 | 90 | 69 | $15K | |
| 72128 | 325 | 267 | $15K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 159 | 136 | $15K |
| 80349 | 1,660 | 991 | $14K | |
| 99233 | Prolong inpt eval add15 m | 602 | 458 | $14K |
| 72070 | 483 | 414 | $14K | |
| 80353 | 1,661 | 991 | $14K | |
| 51705 | 173 | 149 | $14K | |
| 86703 | 926 | 895 | $14K | |
| 72072 | 593 | 509 | $14K | |
| 84146 | 754 | 633 | $14K | |
| 93923 | 152 | 133 | $13K | |
| 82565 | 1,460 | 1,156 | $13K | |
| 80361 | 1,661 | 991 | $13K | |
| 80356 | 1,661 | 991 | $13K | |
| 80358 | 1,661 | 991 | $13K | |
| 80359 | 1,661 | 991 | $12K | |
| 84630 | 796 | 610 | $12K | |
| 86431 | 1,192 | 964 | $12K | |
| 70544 | 153 | 110 | $12K | |
| 83880 | 2,772 | 2,116 | $12K | |
| 82550 | 4,280 | 2,895 | $12K | |
| 82950 | 830 | 714 | $12K | |
| 93270 | 130 | 112 | $12K | |
| 20605 | 67 | 44 | $12K | |
| 81025 | 20,566 | 15,337 | $11K | |
| 72158 | 71 | 52 | $11K | |
| 87102 | 740 | 557 | $11K | |
| 71271 | 59 | 58 | $11K | |
| 83690 | 15,053 | 11,065 | $11K | |
| 72197 | 44 | 33 | $11K | |
| 86147 | 333 | 253 | $11K | |
| 84100 | 2,930 | 1,718 | $11K | |
| 86704 | 787 | 642 | $11K | |
| 86200 | 984 | 841 | $11K | |
| 82670 | 483 | 402 | $11K | |
| 96376 | 5,686 | 2,705 | $10K | |
| 87186 | 3,156 | 2,519 | $10K | |
| 20526 | 60 | 40 | $10K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 985 | 606 | $10K |
| 73590 | 997 | 836 | $10K | |
| 51798 | 1,442 | 1,140 | $10K | |
| 73562 | 989 | 864 | $10K | |
| 82533 | 462 | 361 | $10K | |
| 87640 | 487 | 385 | $10K | |
| 86235 | 720 | 531 | $10K | |
| 91320 | 207 | 159 | $10K | |
| 88304 | 771 | 563 | $10K | |
| 93880 | 108 | 98 | $10K | |
| 83001 | 581 | 499 | $10K | |
| 12011 | 62 | 60 | $9K | |
| 96116 | 64 | 55 | $9K | |
| 86258 | 347 | 278 | $9K | |
| 84425 | 920 | 783 | $9K | |
| 77334 | 31 | 24 | $9K | |
| 10005 | 17 | 14 | $9K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 26 | 13 | $9K |
| J2997 | Injection, alteplase recombinant, 1 mg | 59 | 39 | $9K |
| 88341 | 110 | 70 | $9K | |
| 71101 | 650 | 520 | $9K | |
| 99153 | Mod sedat endo service >5yrs | 394 | 305 | $9K |
| 87641 | 488 | 385 | $8K | |
| 99221 | 442 | 404 | $8K | |
| 88342 | 795 | 611 | $8K | |
| 93225 | 56 | 40 | $8K | |
| 73552 | 611 | 511 | $8K | |
| 82627 | 308 | 249 | $8K | |
| 99252 | 281 | 257 | $8K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 15,363 | 8,684 | $8K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 40 | 32 | $8K |
| 77066 | Tomosynthesis, mammo | 827 | 690 | $8K |
| 86225 | 917 | 702 | $8K | |
| 84156 | 1,922 | 1,500 | $8K | |
| 80321 | 438 | 299 | $8K | |
| 87070 | 1,261 | 872 | $8K | |
| 90651 | 43 | 33 | $8K | |
| 74220 | 118 | 114 | $7K | |
| 83516 | 358 | 331 | $7K | |
| 87493 | 294 | 228 | $7K | |
| 86376 | 461 | 378 | $7K | |
| 99406 | 238 | 204 | $7K | |
| 73080 | 824 | 691 | $7K | |
| 87799 | 414 | 265 | $7K | |
| 73070 | 337 | 270 | $7K | |
| 72114 | 152 | 135 | $6K | |
| 82330 | 3,404 | 2,319 | $6K | |
| 82977 | 754 | 424 | $6K | |
| 95816 | 46 | 38 | $6K | |
| 84480 | 541 | 460 | $6K | |
| 95910 | 96 | 81 | $6K | |
| 28470 | 21 | 14 | $6K | |
| 96130 | 34 | 26 | $6K | |
| 0124A | 230 | 164 | $6K | |
| 80323 | 319 | 236 | $6K | |
| 84402 | 374 | 321 | $6K | |
| 76825 | 90 | 83 | $6K | |
| 73090 | 577 | 479 | $6K | |
| 83020 | 300 | 233 | $6K | |
| 81596 | 34 | 25 | $5K | |
| 83525 | 242 | 203 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,483 | 1,112 | $5K |
| 76870 | 415 | 332 | $5K | |
| J1750 | Injection, iron dextran, 50 mg | 35 | 14 | $5K |
| 72200 | 191 | 168 | $5K | |
| 81003 | 7,245 | 6,362 | $5K | |
| 82105 | 345 | 295 | $5K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,013 | 455 | $5K |
| 93299 | 272 | 259 | $5K | |
| 84550 | 886 | 706 | $5K | |
| 97014 | 137 | 62 | $5K | |
| 74246 | 35 | 29 | $5K | |
| 86160 | 629 | 459 | $5K | |
| 83002 | 377 | 323 | $5K | |
| 99215 | Prolong outpt/office vis | 92 | 88 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 340 | 331 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3,035 | 2,090 | $5K |
| 82077 | 4,387 | 3,215 | $5K | |
| 77002 | 330 | 246 | $5K | |
| 84460 | 531 | 466 | $5K | |
| 83993 | 281 | 229 | $4K | |
| 86800 | 423 | 354 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,005 | 2,385 | $4K |
| 84590 | 429 | 331 | $4K | |
| 00104 | 395 | 110 | $4K | |
| 85730 | 2,841 | 1,994 | $4K | |
| 90480 | 207 | 159 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 20,234 | 15,383 | $4K |
| 72156 | 40 | 37 | $4K | |
| 76821 | 93 | 40 | $4K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 248 | 248 | $4K |
| 84703 | 3,556 | 3,197 | $4K | |
| 90658 | 417 | 403 | $4K | |
| 86039 | 328 | 230 | $4K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 122 | 119 | $4K |
| 87400 | 166 | 142 | $4K | |
| 20552 | 25 | 24 | $4K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 409 | 360 | $4K |
| 78227 | 16 | 12 | $4K | |
| 80164 | 566 | 459 | $4K | |
| 94010 | 70 | 66 | $3K | |
| 51784 | 13 | 12 | $3K | |
| 86923 | 156 | 102 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 44 | 43 | $3K |
| 83615 | 746 | 513 | $3K | |
| 36593 | 17 | 12 | $3K | |
| 93298 | 331 | 308 | $3K | |
| 86787 | 171 | 143 | $3K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 17 | 12 | $3K |
| 00731 | 1,272 | 946 | $3K | |
| 11721 | 192 | 168 | $3K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 43 | 39 | $3K |
| 83521 | 416 | 318 | $3K | |
| 85379 | 2,655 | 1,986 | $3K | |
| 76820 | 78 | 37 | $3K | |
| 83605 | 5,320 | 3,369 | $3K | |
| 76827 | 89 | 82 | $3K | |
| J3490 | Unclassified drugs | 898 | 651 | $3K |
| 87205 | 1,163 | 785 | $3K | |
| 82947 | 3,176 | 2,280 | $3K | |
| 73060 | 347 | 267 | $3K | |
| 80143 | 2,619 | 1,907 | $3K | |
| 82653 | 121 | 96 | $3K | |
| 73523 | 97 | 92 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,462 | 3,586 | $3K |
| 87481 | 296 | 245 | $3K | |
| 73565 | 204 | 164 | $2K | |
| 90832 | Psychotherapy, 30 minutes with patient | 20 | 12 | $2K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 12 | 12 | $2K |
| 36591 | 405 | 257 | $2K | |
| 96132 | 31 | 27 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 71 | 58 | $2K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 777 | 356 | $2K |
| 86308 | 500 | 388 | $2K | |
| 84132 | 3,419 | 2,467 | $2K | |
| 84155 | 601 | 467 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,413 | 913 | $2K |
| 96416 | 62 | 24 | $2K | |
| J1815 | Injection, insulin, per 5 units | 246 | 156 | $2K |
| 64636 | 173 | 126 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 12 | 12 | $2K |
| 96136 | 32 | 24 | $2K | |
| 84165 | 463 | 363 | $2K | |
| 82040 | 250 | 218 | $2K | |
| 83520 | 59 | 38 | $2K | |
| 85045 | 684 | 491 | $2K | |
| 86146 | 172 | 138 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,777 | 1,871 | $2K |
| 82103 | 160 | 124 | $2K | |
| 87338 | 100 | 85 | $2K | |
| 96146 | 14 | 14 | $2K | |
| 90746 | 116 | 94 | $2K | |
| 86705 | 43 | 43 | $2K | |
| J3489 | Injection, zoledronic acid, 1 mg | 104 | 76 | $2K |
| 87040 | 1,657 | 744 | $2K | |
| 85018 | 1,235 | 848 | $2K | |
| 86334 | 115 | 95 | $2K | |
| J9263 | Injection, oxaliplatin, 0.5 mg | 90 | 37 | $2K |
| 90739 | 138 | 116 | $2K | |
| 97012 | 34 | 12 | $2K | |
| 96402 | 171 | 119 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 16,239 | 10,270 | $1K |
| 76942 | 361 | 275 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 535 | 381 | $1K |
| 82951 | 55 | 53 | $1K | |
| 85014 | 255 | 183 | $1K | |
| 97032 | 24 | 12 | $1K | |
| 80179 | 2,570 | 1,879 | $1K | |
| 93922 | 14 | 12 | $1K | |
| 72146 | 12 | 12 | $1K | |
| 82378 | 187 | 137 | $1K | |
| 82150 | 233 | 181 | $1K | |
| 87536 | 42 | 39 | $1K | |
| 86317 | 50 | 50 | $1K | |
| 80178 | 180 | 131 | $1K | |
| 82375 | 2,773 | 2,005 | $1K | |
| 99401 | 16 | 16 | $1K | |
| 82310 | 149 | 120 | $1K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 839 | 622 | $1K |
| 84134 | 112 | 81 | $1K | |
| C9113 | Injection, pantoprazole sodium, per vial | 697 | 340 | $1K |
| 80177 | 208 | 173 | $1K | |
| 86256 | 63 | 45 | $1K | |
| 90662 | 192 | 169 | $1K | |
| 99253 | 32 | 29 | $1K | |
| 86695 | 50 | 41 | $1K | |
| 82803 | 2,036 | 1,448 | $1K | |
| J1644 | Injection, heparin sodium, per 1000 units | 3,707 | 1,329 | $1K |
| 94618 | 14 | 13 | $1K | |
| 00840 | 413 | 229 | $1K | |
| 86709 | 59 | 59 | $995.60 | |
| 51729 | 13 | 12 | $979.78 | |
| 86708 | 37 | 25 | $969.64 | |
| J1453 | Injection, fosaprepitant, 1 mg | 79 | 43 | $958.85 |
| J9045 | Injection, carboplatin, 50 mg | 109 | 52 | $958.58 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 110 | 83 | $954.49 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 4,185 | 2,049 | $953.87 |
| 73600 | 83 | 56 | $925.76 | |
| 82785 | 82 | 72 | $922.13 | |
| 87045 | 52 | 41 | $896.26 | |
| 85041 | 251 | 170 | $894.50 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 4,475 | 3,752 | $879.57 |
| 99222 | Initial hospital care, per day, moderate complexity | 25 | 24 | $857.12 |
| 77091 | 39 | 39 | $838.80 | |
| 86359 | 18 | 16 | $817.49 | |
| J1790 | Injection, droperidol, up to 5 mg | 1,663 | 1,105 | $808.89 |
| 83050 | 2,408 | 1,751 | $803.60 | |
| 86696 | 50 | 41 | $795.73 | |
| 80354 | 825 | 479 | $786.59 | |
| 99254 | 13 | 13 | $712.83 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 399 | 353 | $711.76 |
| 84295 | 2,951 | 2,110 | $709.46 | |
| 76818 | 17 | 12 | $700.05 | |
| 64494 | 420 | 307 | $699.85 | |
| 76937 | 74 | 64 | $694.66 | |
| J2704 | Injection, propofol, 10 mg | 9,494 | 6,547 | $693.06 |
| 84270 | 43 | 40 | $678.02 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,706 | 4,689 | $674.84 |
| 82435 | 2,005 | 1,497 | $666.87 | |
| 73000 | 28 | 26 | $655.53 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,896 | 3,692 | $623.38 |
| 82248 | 65 | 51 | $621.07 | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 258 | 142 | $620.81 |
| 85613 | 39 | 37 | $610.07 | |
| 90686 | 48 | 39 | $605.02 | |
| 87529 | 17 | 13 | $598.50 | |
| 86765 | 30 | 25 | $598.46 | |
| 51700 | 24 | 13 | $572.76 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 890 | 476 | $571.50 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 2,443 | 1,516 | $568.68 |
| 84445 | 14 | 12 | $517.13 | |
| 72220 | 30 | 26 | $494.80 | |
| 82525 | 47 | 41 | $475.03 | |
| 86735 | 22 | 13 | $468.84 | |
| 87449 | 56 | 44 | $465.57 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 31 | 27 | $465.45 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 9,381 | 5,247 | $464.81 |
| 87046 | 52 | 41 | $448.88 | |
| 77001 | 64 | 54 | $446.48 | |
| 95909 | 25 | 25 | $437.91 | |
| 82140 | 91 | 75 | $435.21 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 1,321 | 853 | $434.38 |
| 90461 | 47 | 36 | $423.73 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 18 | 18 | $412.85 |
| 84144 | 12 | 12 | $377.65 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 16,994 | 9,677 | $376.93 |
| 82952 | 25 | 24 | $362.79 | |
| 00811 | 148 | 101 | $362.46 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 137 | 108 | $356.42 |
| 86361 | 13 | 12 | $349.78 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,961 | 2,183 | $346.72 |
| 73501 | 40 | 38 | $336.60 | |
| 99225 | 28 | 25 | $331.27 | |
| 84145 | 88 | 68 | $326.09 | |
| 51701 | 17 | 12 | $323.02 | |
| 92610 | 13 | 13 | $309.91 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,611 | 855 | $309.33 |
| 82390 | 17 | 13 | $303.99 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,452 | 868 | $290.06 |
| 85384 | 73 | 47 | $289.43 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,869 | 2,851 | $285.86 |
| 87328 | 17 | 13 | $276.22 | |
| 51797 | 13 | 12 | $267.33 | |
| 88311 | 73 | 56 | $257.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 973 | 546 | $247.05 |
| J2785 | Injection, regadenoson, 0.1 mg | 756 | 553 | $244.60 |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,465 | 1,922 | $230.70 |
| 84681 | 14 | 12 | $218.54 | |
| 73660 | 13 | 13 | $216.75 | |
| 84207 | 18 | 18 | $215.39 | |
| 84450 | 46 | 42 | $213.46 | |
| 82010 | 387 | 292 | $210.81 | |
| 83090 | 20 | 13 | $204.51 | |
| 80175 | 16 | 13 | $190.97 | |
| 96417 | 808 | 387 | $184.55 | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 77 | 33 | $179.94 |
| 95912 | 40 | 40 | $168.32 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 242 | 145 | $156.49 |
| J2060 | Injection, lorazepam, 2 mg | 1,293 | 786 | $154.89 |
| 82274 | 22 | 13 | $151.63 | |
| 83721 | 48 | 44 | $149.60 | |
| 95911 | 40 | 38 | $148.63 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,715 | 1,897 | $146.73 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 720 | 609 | $137.36 |
| J1940 | Injection, furosemide, up to 20 mg | 628 | 297 | $134.79 |
| 87075 | 73 | 62 | $132.76 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 465 | 310 | $130.46 |
| 88112 | 98 | 66 | $126.43 | |
| 86301 | 21 | 16 | $126.16 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 5,696 | 3,666 | $126.01 |
| 86790 | 31 | 28 | $124.56 | |
| 87329 | 17 | 13 | $119.32 | |
| 82747 | 13 | 12 | $112.56 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 152 | 57 | $110.57 |
| 84075 | 14 | 13 | $103.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,677 | 1,050 | $97.60 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 696 | 577 | $97.13 |
| 96139 | 13 | 12 | $85.06 | |
| 80047 | 28 | 25 | $84.40 | |
| 88173 | 28 | 26 | $81.99 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,196 | 1,050 | $80.56 |
| J3411 | Injection, thiamine hcl, 100 mg | 70 | 38 | $79.80 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 2,828 | 2,357 | $69.01 |
| 81002 | 61 | 48 | $68.73 | |
| 86381 | 14 | 13 | $67.06 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,873 | 1,915 | $66.50 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 477 | 310 | $65.67 |
| J3480 | Injection, potassium chloride, per 2 meq | 1,016 | 598 | $63.36 |
| 86304 | 20 | 12 | $58.43 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 13 | 12 | $53.88 |
| 82365 | 40 | 24 | $50.70 | |
| 88302 | 15 | 12 | $45.62 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 221 | 144 | $37.48 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 222 | 181 | $36.48 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 111 | 65 | $35.08 |
| A9270 | Non-covered item or service | 2,422 | 1,388 | $33.50 |
| 86255 | 25 | 24 | $29.61 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 131 | 72 | $25.15 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 27 | 17 | $23.52 |
| 91300 | 2,122 | 1,923 | $20.80 | |
| J7050 | Infusion, normal saline solution, 250 cc | 4,905 | 2,423 | $19.45 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 162 | 77 | $17.98 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 506 | 292 | $17.37 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 211 | 157 | $13.20 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 847 | 453 | $11.97 |
| J1630 | Injection, haloperidol, up to 5 mg | 77 | 45 | $11.94 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 103 | 89 | $10.37 |
| 85007 | 14 | 12 | $9.45 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 27 | 14 | $8.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 254 | 193 | $5.97 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 62 | 59 | $5.09 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 245 | 115 | $3.72 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 233 | 154 | $3.60 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 1,784 | 1,372 | $2.94 |
| J0456 | Injection, azithromycin, 500 mg | 46 | 24 | $2.72 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 72 | 34 | $2.68 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,055 | 987 | $1.18 |
| 91312 | 104 | 61 | $0.73 | |
| C1769 | Guide wire | 996 | 684 | $0.00 |
| 76377 | 130 | 116 | $0.00 | |
| 3074F | 459 | 444 | $0.00 | |
| 01480 | 16 | 12 | $0.00 | |
| 94760 | 1,212 | 529 | $0.00 | |
| 00813 | 63 | 52 | $0.00 | |
| 3079F | 57 | 55 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 252 | 219 | $0.00 |
| 64484 | 45 | 42 | $0.00 | |
| A4648 | Tissue marker, implantable, any type, each | 270 | 206 | $0.00 |
| 36416 | 99 | 92 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 83 | 83 | $0.00 |
| 87081 | 32 | 26 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 190 | 69 | $0.00 |
| 00790 | 147 | 96 | $0.00 | |
| 96411 | 93 | 38 | $0.00 | |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 33 | 32 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 38 | 27 | $0.00 |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 16 | 12 | $0.00 |
| 3078F | 359 | 348 | $0.00 | |
| 0598T | 18 | 14 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 520 | 475 | $0.00 |
| 00910 | 43 | 39 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 60 | 57 | $0.00 |
| 00918 | 20 | 12 | $0.00 | |
| 00400 | 54 | 41 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 33 | 26 | $0.00 |
| 51741 | 13 | 12 | $0.00 | |
| 96133 | 15 | 13 | $0.00 | |
| C2625 | Stent, non-coronary, temporary, with delivery system | 33 | 24 | $0.00 |
| J9190 | Injection, fluorouracil, 500 mg | 128 | 37 | $0.00 |
| C1788 | Port, indwelling (implantable) | 12 | 12 | $0.00 |